Interestingly, increase of SET expression in brains of patients with Alzheimer’s disease has been associated with the accumulation of phosphorylated Tau in neurons through inhibition of PP2A activity by SET [61,62,63]. The gene discussed is MAPT; the disease is Alzheimer disease.